No products in the cart.

Anti-CD98 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-4802
Anti-CD98 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-4802
Product type: Primary antibody
Antigen: CD98
Immunogen: A synthetic peptide derived from C-terminal region of human SLC3A2. The exact amino-acid sequence is 491-540.
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:400-1:2000)
Reactivity: Human, Mouse, Rat
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: 1*PBS (pH7.4), 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Concentration: 1 mg/ml
Purity: Immunogen affinity purified.
Storage: Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles.
Conjugate: Non-conjugated
Alternative names: SLC3A2 antibody; MDU1 antibody; 4F2 cell-surface antigen heavy chain antibody; 4F2hc antibody; 4F2 heavy chain antigen antibody; Lymphocyte activation antigen 4F2 large subunit antibody; CD98 antibody
Show More

Target information

Component of several heterodimeric amino acid transporter complexes (PubMed:11557028, PubMed:9829974, PubMed:9751058, PubMed:10391915, PubMed:10574970, PubMed:11311135). The precise substrate specificity depends on the other subunit in the heterodimer (PubMed:9829974, PubMed:9751058, PubMed:10391915, PubMed:10574970, PubMed:30867591, PubMed:10903140). The heterodimer with SLC3A2 functions as sodium-independent, high-affinity transporter that mediates uptake of large neutral amino acids such as phenylalanine, tyrosine, L-DOPA, leucine, histidine, methionine and tryptophan (PubMed:9751058, PubMed:11557028, PubMed:11311135, PubMed:11564694, PubMed:12117417, PubMed:12225859, PubMed:25998567, PubMed:30867591). The complexes with SLC7A6 and SLC7A7 mediate uptake of dibasic amino acids (PubMed:9829974, PubMed:10903140). The complexes function as amino acid exchangers (PubMed:11557028, PubMed:10903140, PubMed:12117417, PubMed:12225859, PubMed:30867591). Required for targeting of SLC7A5 and SLC7A8 to the plasma membrane and for channel activity (PubMed:9751058, PubMed:11311135, PubMed:30867591). Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. The heterodimer with SLC7A5/LAT1 may play a role in the transport of L-DOPA across the blood-brain barrier (By similarity). May mediate blood-to-retina L-leucine transport across the inner blood-retinal barrier (By similarity). The heterodimer with SLC7A5/LAT1 can mediate the transport of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane (PubMed:11564694, PubMed:12225859). When associated with SLC7A5 or SLC7A8, involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane (PubMed:15769744). The heterodimer with SLC7A5 is involved in the uptake of toxic methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes (PubMed:12117417). Together with ICAM1, regulates the transport activity SLC7A8 in polarized intestinal cells, by generating and delivering intracellular signals. When associated with LAPTM4B, the heterodimer formed by SLC3A2 and SLC7A5 is recruited to lysosomes to promote leucine uptake into these organelles, and thereby mediates mTORC1 activation (PubMed:25998567).

Provider

Erpantech Laboratory